Skip to main content
Investors
Investors Menu

Investors

Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Press release | Financial news
July 16, 2024

Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close. The company will also host a conference call that...

Read more

stock ticker
NYSESOLV
Company overview

A new healthcare company with a rich history

With more than 70 years of delivering healthcare innovations, we continue to move the industry forward by helping to solve our customers’ biggest challenges.

  • $8.2 billionin sales in 2023
  • Approximately 22,000professionals shaping the future of health
Events & Presentations
Events Businessperson speaking at microphone in front of crowd
Solventum Corp. Q2 2024 Earnings
Thursday, August 8, 2024
4:30pm - 5:30pm EDT
Add to Calendar
Set Email Reminder

See all events

Press releases
Press release
Jul 16, 2024
Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close. The company will also host a conference call that...

Read more

Press release
Jun 7, 2024
Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"

Solventum (NYSE: SOLV) has been notified that TRC Capital Investment Corporation ("TRC") made an unsolicited "mini-tender offer" to purchase up to 2,000,000 shares of the company's common stock at...

Read more

Press release
May 9, 2024
Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update

Completed spin-off from 3M and began trading on April 1, 2024 Reported sales increased 0.2% to $2.016 billion, organic sales increased 0.9% GAAP Earnings Per Share (EPS) of $1.37; adjusted EPS1 of...

Read more

See all financial news

Resources

We enable better, smarter, safer healthcare to improve lives

Learn more about our priorities and how we are uniquely positioned to transform healthcare.

Governance

Read about our governance priorities and our commitment to accountability.

View governance

Leadership

Meet our corporate officers and board of directors.

View leadership

SEC filings

Find information and links to statements filed with the SEC.

View SEC filings

Media center

Discover our latest news and announcements.

View media center

Investor alerts

Sign up today and receive company updates straight to your inbox.

Subscribe

Contact Investor Relations

These contacts are intended only for shareholders. If you are not a shareholder, please call 1-855-423-6725 (1-855-HC FOR ALL).

General inquiries:
investors@solventum.com

Contact us

Transfer agent contact information:

EQ Shareowner Services
P.O. Box 64854
St. Paul, MN 55164-0854
Toll Free: 1-888-666-0140   
Tel: 1-651-450-4064 (outside the United States)

An automated voice response system is available 24 hours a day, 7 days a week. Customer service representatives are available from 7:00 a.m. to 7:00 p.m., Central Standard Time, Monday through Friday.

Account information
https://www.shareowneronline.com